Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Elelyso (taliglucerase alfa)
pCPA File Number:
20999
Negotiation Status:
Concluded with an LOI
Indication(s):
Gaucher disease
Sponsor/Manufacturer:
Pfizer Canada ULC
CADTH Project Number:
Not Applicable
pCPA Engagement Letter Issued:
2017-11-17
Negotiation Process Concluded:
2018-05-17